The Food and Drug Association (FDA) has recently cleared the use of Renishaw’s neuromate® Gen III surgical robot with the neuroinspire™surgical planning software in the USA. Both were previously cleared for use separately, but not in combination ─ This latest clearance means that neurosurgeons across America will now be able to deliver surgical plans created using neuroinspire software directly using the neuromate surgical robot, helping to improve patient outcomes.
